Nicholas C. Richardson

Author

Also Known As

Nicholas C Richardson, Nicholas C. Richardson, Nicholas Richardson

Publications

414

Citations

H-Index

Concepts

All Affiliations

Nicholas C. Richardson is an author at Center for Drug Evaluation and Research specializing in oncology, medicine, and pathology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	202
2	Pathology	3	3	202
3	Health Sciences	2	2	107
4	Immunology	1	1	74
5	Pharmacology	1	1	95

Nicholas C. Richardson

Publications

263

Citations

H-Index

Page 1

	Year	Citations
The saga of PI3K inhibitors in haematological malignancies: survival is the ultimate safety endpoint Nicholas C. Richardson, Yvette L. Kasamon, Richard Pazdur, The Lancet Oncology Pi3k InhibitorsOncologyMedicineHaematological MalignanciesPathology	2022	95
FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell Lymphoma Nicholas C. Richardson, Yvette L. Kasamon, Haiyan Chen, The Oncologist ImmunologyPathologyPharmacotherapyImmunotherapeuticsImmunotherapy	2019	74
FDA approval summary: Crizotinib for pediatric and young adult patients with relapsed or refractory systemic anaplastic large cell lymphoma Margret Merino, Yvette L. Kasamon, Hongshan Li, Pediatric Blood & Cancer Lymphoid NeoplasiaU.s. FoodMedicineMetronomic TherapyObjective Response Rate	2022	33
Impact of Total Shoulder Arthroplasty on Golfing Activity Dean N. Papaliodis, Nicholas C. Richardson, Jason P. Tartaglione, Clinical Journal of Sport Medicine	2014	32
Computer Assisted Cobb Angle Measurements: A novel algorithm Dean N. Papaliodis, Pierino G. Bonanni, Timothy T. Roberts, The International Journal of Spine Surgery	2017	19
Minimal Residual Disease Data in Hematologic Malignancy Drug Applications and Labeling: An FDA Perspective Andrea Baines, Maryam Sarraf Yazdy, Yvette L. Kasamon, Clinical Cancer Research	2023	10

Page 1